The newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Eli Lilly & Co. said Tuesday that patients can now access 2.5- and 5-milligram single-dose vials of its weight-loss treatment ...

The FDA approval of Zepbound could also have some unintended ... a GLP-1 FDA approved drug for diabetes but often prescribed for its off-label use of weight loss. The FDA received reports that ...

Zepbound is a prescription injectable medication that’s used for weight loss. You or a caregiver can administer it as a subcutaneous injection into your stomach or thigh. A caregiver can also ...

Eli Lilly and Company LLY announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed rival Novo Nordisk’s NVO Wegovy (semaglutide) in a weight-loss head-to ...

Studies show Zepbound can improve the condition by reducing ... Mounjaro to treat Type 2 diabetes and became popular as an off-label weight-loss treatment. Tirzepatide works by stimulating two ...

The analysts expect launches of medicines including Eli Lilly’s Zepbound and Novo Nordisk ... heart failure in 2021 and secured an expanded label in a hard-to-treat population the next year.